Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2.59M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
3.23M
-
Shares change
-
+523K
-
Total reported value, excl. options
-
$1.33M
-
Value change
-
+$214K
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$0.41
Significant Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q3 2024
24 filings reported holding APTO - Aptose Biosciences Inc. - Common Shares as of Q3 2024.
Aptose Biosciences Inc. - Common Shares (APTO) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.23M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.89M shares), DRW Securities, LLC (593K shares), Sigma Planning Corp (402K shares), UBS Group AG (133K shares), Nantahala Capital Management, LLC (77.3K shares), MORGAN STANLEY (31.4K shares), TWO SIGMA SECURITIES, LLC (30.4K shares), Annandale Capital, LLC (26.7K shares), Cetera Investment Advisers (19.2K shares), and Texas Capital Bank Wealth Management Services Inc (12.4K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.